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Abstract 
Intervertebral disc engineering confronts many challenges owing to its complexity 
and the presence of extraordinary stresses. However, rebuilding a disc of native 
function could be useful for the removal of the symptoms, and the correction of 
altered spine kinematics that are associated with disc degeneration. Improvement in 
the understanding of disc properties and techniques for its engineering brings promise 
to the fabrication of a functional motion segment for the treatment of disc 
degeneration. While whole disc engineering is premature relative to articular cartilage 
engineering, the increasing sophistication of techniques available in biomedical 
sciences will eventually bring its application into clinics. In this review we give an 
account of the current progress and challenges of intervertebral disc bioengineering, 
and discuss possible means to move forward and towards bedside translation. 
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Introduction 
Disease conditions are often manifested with the disruption of tissue structure and 
function, in which the body is incapable of repairing. Advancement in various 
disciplines including cell biology, developmental genetics, materials science, and 
biomechanics, has brought the realization that tissue engineering could assist tissue 
repair or replacement. Unlike cartilage engineering, the engineering of the 
intervertebral disc (IVD) confronts many challenges owing to its complexity and 
presence of extraordinary stresses related to its architecture and function. The IVD 
plays a crucial role in articulation of the spinal column and contributes to various 
body postures and force coordination in daily activities. Along with its role in 
articulation, the IVD has a major function in providing cushioning effects to the spine 
against axial load. As a result of the intensive mechanical stress, the IVD suffers from 
degeneration in a similar fashion to articular cartilage in loaded appendicular joints. 
The causes of IVD degeneration are not clear, although it is thought to be 
multifactorial with a large contribution from both genetic and environmental 
components [1,2], and may share common biological components exhibited in 
osteoarthritis [3]. Current treatments predominantly aim not to correct the 
degeneration, but alleviate symptoms such as back pain and sciatica which are often 
manifested by severe IVD degeneration or radiculopathy caused by prolapse of the 
degenerated disc. Conventional modalities range from surgical means such as spinal 
segment fusion, laminectomy, and total disc/nucleus replacement, to non-invasive 
physiotherapies such as ultrasound electrotherapy and traction.  
 
Current theory suggests that when the IVD is degenerated, the articular unit has 
compromised mechanical function and subsequently, the motion segment becomes 
unstable under load. Consequently, this may result in significant pain and 
	   4	  
neurological irritations that can cause a severe decrease in daily activities of the 
individual. While intervertebral fusion, the ‘gold standard’ for treating symptomatic 
disc degeneration may stabilize the segment and relieve symptoms, juxtalevel 
degeneration may occur due to the observed hypermobility of the IVD adjacent to the 
fused segment [4]. Rebuilding an IVD of native function that allows appropriate 
interplay with other motion segment components including the facet joints and 
ligaments, could therefore be promising in the removal of symptoms whilst 
simultaneously reestablishing spine kinematics. A recent study of IVD allograft 
transplantation to treat cervical disc herniation in humans supports this notion [5]. 
Whilst total disc replacement may potentially resolve the issue in a similar manner, 
long-term results suggest that artificial disc replacements frequently result in 
spontaneous fusion, and is considered to be an expensive spacer for fusion [6]. 
Bioengineering of the IVD may therefore provide an alternative solution to address 
the issue.  
 
Tissue engineering can be achieved at different levels of complexity, from cell 
programming and scaffold modeling, to cell-scaffold composite construction and 
multi-scale tissue fabrication. Advances in our understanding of IVD properties and 
techniques in its engineering at each of the levels may impact on the success of 
building a functional motion segment for treating disc degeneration. In this review, 
we give an account of the progress and challenges of IVD engineering, and propose 
what is needed to move forward and towards bedside translation. 
 
Disc cell engineering 
The IVD is composed of multiple subunits that integrate seamlessly to form 
sophisticated and complex mechanical function. It has three main structures: a 
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gelatinous nucleus pulposus (NP) core wrapped around and confined by a fibrous 
lamella structure, the annular fibrosus (AF), and cartilaginous endplates (CEP) of the 
vertebrae sandwiching the NP and AF. The three compartments are different in 
mechanical properties and are functionally dependent on each other. These 
compartments are made up of various matrix components, predominantly collagens 
and proteoglycans, and comprise of different cells that are thought to play roles in 
maintaining the matrix integrity. From a developmental point of view, IVD formation 
involves the diversification of cells from a primitive anlage consisting of the 
notochord and its surrounding mesenchymal cells, a process that involves vigorous 
cell differentiation during the embryonic stage, and continual postnatal remodeling of 
its microenvironment including the extracellular matrices [7,8,9]. 
 
The primary role of the IVD is to provide mechanical support and motion, which is 
largely attributed to the viscoelastic properties (the viscous and elastic behavior under 
deformation) of the IVD [10]. IVD-like properties and function may possibly be 
obtained by simply using acellular scaffolds or devices. However, materials with 
desirable viscoelastic properties pertaining to IVD are often biodegradable and 
therefore their function may not be sustained in the long-term. Cell-containing 
constructs are advantageous with cells enable to remodel the scaffold template, 
thereby maintaining or enhancing matrix integrity. More importantly, IVD 
transplantation studies have demonstrated the integration of disc allograft to recipient 
vertebrae by biological remodeling at the endplates, including that of mis-aligned 
discs which were also found to self-correct post surgery [5]. Since the self-correction 
is considered to eventually contribute to motion segment kinematics and stability in 
the long term, cellular IVD constructs would theoretically outperform acellular 
prosthetic devices in function. 
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The loss of integrity and viscoelasticity of the NP is one of the earliest observable 
events in disc degeneration, suggesting that the engineering of the NP is crucial to the 
success of a functional IVD construct. Considerable effort has been invested into 
understanding the NP, in particular, delineating the NP cell phenotype so as to 
facilitate NP cell engineering for the creation of cellular IVD constructs. Two cell 
populations are thought to exist in the NP: small non-vacuolated cells with a 
chondrocyte-like phenotype, and large vacuolated cells which are often referred to as 
notochordal cells [11]. The large vacuolated NP cells have been shown to originate 
from the notochord [8], whereas controversy still surrounds the origin of the 
chondrocyte-like cells, particularly in human NP. Nevertheless, recent studies have 
provided some insights to the molecular identity of the latter type of cells based on 
microarray-based gene expression profiles of NP cells from adult human [12], bovine 
[13], and chondrodystrophoid dog [14]. Notably, these studies did not yield common 
genetic markers that is translatable among different species, but rather, indicated the 
presence of species-specific markers, for example PAX1 and FOXF1 in human, A2m 
and Anxa4 in canine, and Snap25 and Krt8 in bovine. Expression profile studies of 
rodent NP cells [15], which predominantly consist of large vacuolated notochordal 
cells, also suggested that markers may not be shared with human NP cells, and 
indicated that notochordal and chondrocyte-like NP cells may be distinct in 
phenotypes. This is supported by cell sorting studies in which the two populations 
were separately extracted from the same animal for comparative analyses [13,16]. 
Nevertheless, recent studies suggest that a crosstalk may possibly exist between the 
two cell populations, complicating the search of the true NP cell identity [17][18].  
 
IVD and articular cartilage have different mechanical properties. The transplantation 
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of chondrocyte-like cells or the use of such cells in the engineering of NP constructs 
may not produce a disc with ideal function. On the other hand, future IVD 
engineering will likely utilize stem cells and other progenitor cell types to 
differentiate into NP cells and generate them in large quantity. Unless the phenotype 
and the functional characteristics of the notochordal and chondrocyte-like NP cell 
types are clearly defined, the generation of authentic NP cells from stem/progenitor 
cells and hence bioengineering of NP with native mechanical properties may not be 
achieved. In vitro studies have suggested that stimulation by co-culturing with NP 
cells [20,21,22,23], induction of chondrogenic transcription factor SOX9 [24,25] or 
stimulation by chondrogenic growth factors TGF-β1 (transforming growth factor beta 
1) [25,26,27] are attractive strategies to drive differentiation of adult stem cells, such 
as mesenchymal stem cells, into NP-like cells. However, whether or not the 
differentiated cells have attained an authentic NP cell or chondrocyte-like phenotype 
remains elusive. Engineering the NP with chondrocytes is not desirable since it is 
likely that the construct will become hyaline cartilage instead of NP tissue and hence 
possesses inappropriate viscoelastic properties.  
 
AF cells are generally referred to as fibrochondrocytes. This phenotype is based on 
the ability of AF cells to produce collagen I and III, in addition to collagen II and 
aggrecan which are produced to a lower extent [28]. Compared to NP cells, the 
molecular phenotype of AF cells and their changes in disc degeneration is less clear. 
While NP and AF are morphologically different and supposedly have different cell 
phenotypes, recent transcription profiling studies indicated that AF cells express a 
large number of non-house-keeping genes at similar level to that of NP cells 
[12,13,14]. Nevertheless, other potential markers are suggested to be differentially 
expressed at higher levels in the AF relative to the NP, for example VCAM1 in human 
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[12]. Fibromodulin has been shown to be a specific marker of the AF in rodent [30], 
however, its expression pattern in humans or large animal models is unclear. On the 
other hand, while the CEP is assumed to be analogous to hyaline cartilage and 
consists of chondrocytes, the molecular phenotype of CEP cells is also not clear, and 
that there is a lack of evidence that demonstrates their similarities. In fact, histological 
findings have suggested that there is a difference in the glycosaminoglycan 
composition and collagen VI and X expression between CEP and growth plate 
cartilage [9,31]. It is not clear whether or not the use of chondrocytes in 
bioengineering can fully fulfill the function of the CEP. 
 
Engineering the disc microenvironment 
The bulk of the IVD is composed of extracellular matrix which plays prominent roles 
in the regulation of the disc cell environment and providing anchorage to disc cells. 
The extracellular matrix of the IVD, like cartilage, is comprised of mostly collagens 
which provide tensile strength of the disc [32], and proteoglycans, which function to 
reduce the internal friction in the disc matrix and to distribute load [33]. Importantly, 
they also account for the viscoelastic behavior of the IVD, contributing to the shock 
absorbing property [34]. Based on the relationship between function and form, 
materials that can mimic the anatomic architecture and mechanical properties of 
native IVD (reviewed by Nerurkar et al [10]) are of interest to disc bioengineers. 
 
Like hyaline cartilage, aggrecan and collagen II are the two main extracellular matrix 
components of mature NP. Although the NP in mature human IVD is thought to be 
analogous to articular cartilage, the nature of the matrix and hence their mechanical 
properties are not exactly the same [35]. NP in young individuals have a high 
proteoglycan to collagen content, with a suggested GAG to hydroxyproline ratio of 
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27:1, in comparison to a 2:1 ratio in hyaline cartilage [36]. The high proteoglycan 
content in the NP matrix facilitates the retainment of water which attributes to the 
high hydrostatic pressure exhibited in the NP. Hydrogel scaffolds have been 
commonly used with the intention of simulating the NP microenvironment and 
entrapment of the newly deposited proteoglycan to facilitate the establishment of 
hydrostatic pressure. The effectiveness of various hydrogel-based scaffolds, either 
made from natural hydrophilic biomolecules or synthetic polymers, for NP 
engineering or repair has been documented. To date, alginate is one of most 
commonly adopted hydrogel scaffolds for NP cell culturing [37,38] due to its ease of 
manipulation, biodegradability and inert bioactivities. Hyaluronic acid (HA) has been 
used for the treatment of osteoarthritic knee joints via the direct application into the 
synovial cavity, and in vivo studies propose that HA [39,40,41,42] or HA-derived 
hydrogel [43,44,45] may facilitate NP function and promote motion segment 
mechanics. However, because the NP plays an important role in withstanding the 
compressive load so as to maintain disc height and range of motion of spinal segment, 
pure hydrogel scaffolds, which lack confined compressive strength, may not be 
adequate for NP engineering. Collagen I microspheres [46,47] and calcium 
polyphosphate [48] may on the other hand provide good tensile and compressive 
strength to support stem cells or NP cells in NP engineering. Recent studies have 
focused on the generation of collagen-incorporated [50,51,52] or polymer-linked 
[53,54] hydrogels. These hybrid scaffolds mimic the native microenvironment of the 
NP to reproduce its viscoelastic and load distribution behavior within the IVD. In fact, 
while swelling is known to provide the main load-bearing mechanism in the NP, the 
extensive collagen network inside the disc has also been suggested to support a 
considerable portion of load as the collagen fibril meshwork contributes to the 
compressive modulus to the tissue [55]. Moreover, collagens have been shown to act 
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as a reservoir of signaling ligands, such as TGF-β1 and BMP-2 for collagen II [56], 
and are able to transduce mechanical signals [57,58], therefore serving as important 
regulators of cell function and homeostasis. 
 
In addition to NP engineering, current research has attempted to use injectable 
scaffolds as carriers to deliver cells with the aim of salvaging disc degeneration or on 
its own, as fillers for NP replacement using a minimally invasive approach [52]. 
Studies have also developed injectable materials that have the ability to self-assemble 
into a higher-order network, resulting in a sol-gel (solution-to-gel) transition. For 
example, atelocollagen (pepsin-digested collagen) can self-crosslink to form a fibrous 
meshwork [59,60], and chitosan [27,61] and synthetic peptides [62,63,64] have been 
reported to self-assemble into a nanofiber network. Other natural biomolecules 
including hyaluronan and chitosan, when modified with crosslinkable moieties, are 
capable of chain polymerization through photochemical reactions [65]. These 
materials, as injectable media, may deliver cells of interest by providing a transient 
framework that prevents leakage of implants and allow for the accumulation of the 
extracellular matrix deposited by the introduced cells. 
 
While intradiscal pressure exerted by the NP plays an important role in disc function, 
it critically depends on the integrity of the AF. In addition, the trans-AF delivery 
system remains the commonly used way to manipulate the NP in clinical and 
experimental settings. The construction of AF may facilitate the repair of prolapsed 
discs and supplement nucleus replacement. Annulus closure devices [66] may 
possibly provide an effective means to treat prolapsed discs, however, may restrict 
segment motion and possibly modify the load distribution in the IVD. AF 
construction is understandably indispensable to IVD engineering, but effective 
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bioengineering of AF may not be implemented without proper understanding of its 
microstructure and mechanics.  
 
The AF lamellae are mainly composed of collagen I fiber bundles and have 
anisotropic mechanical behavior [67]. These bundles are approximately concentric to 
the lamellae around the NP, where the direction of alignment in one lamella differs to 
the next by 30° [68]. This angle-ply architecture of lamellae is thought to be designed 
to resist shear resulting from complex physiological stresses such as a combination of 
axial loading and torsion [69,70]. Annulus fibers are interconnected via intra-lamellar 
cross-bridges [71] and inter-lamellar bridges [72,73]. In vitro studies showed that 
excess circumferential constraint may negatively impact on NP cell metabolic 
activities [75], which suggests that tissue rigidity needs to be carefully controlled 
during AF construction. The rigidity of the AF largely depends on the mechanical 
properties of the materials used during fabrication. Various materials have been tested 
for AF tissue construction, and include porous silk [76,77], polymer nanofibers 
[40,69,78,79], polylactide/Bioglass composite [80], and alginate/chitosan composite 
[81]. These scaffolds provide a framework of desirable mechanical and bioinductive 
properties for future AF engineering. An alternative is collagen gel [82,83] or 
collagen-GAG composite [84], although fabrication into a specific geometry (such as 
fibers or lamella) or characteristic topographical template may be limited. Since AF 
cells are normally aligned with the lamella fibers, it may be ideal that AF constructs 
can be engineered through simultaneous controlled placement of AF cells and 
orientation of the matrix they interact with, such as using scaffolds with specifically 
designed micro-grooves [85].  
 
Collagen fiber structure determines the mechanical strength and elasticity of the 
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annulus. Recent studies in AF engineering have shed light on some important aspects 
of its structural properties at the molecular level. Nerurkar et al showed that, through 
electrospun nanofiber fabrication, a bi-lamellar tissue model with AF-like angle-ply 
architecture can be generated [70,86]. By mechanical testing and modeling, they 
demonstrated that the bonding between the angle-ply lamellae is crucial to the 
resistance of inter-lamellar matrix to local deformations and therefore functions to 
reinforce the overall tensile response of AF architecture. Moreover, an in vitro study 
indicated that fibronectin can play a pivotal role in facilitating AF cell attachment and 
alignment on nanofibers [87], implying that a synergy between collagen and other 
non-collagen matrix components may be required to provide AF cells a niche to attain 
appropriate activities. Altogether, these findings indicate that the AF structure is not 
just a multi-layered fibrous tissue, but built with a sophisticated hierarchy of intra- 
and inter-lamellar supramolecular interactions.  
 
The CEP is involved in attachment of both AF and NP fibers [88]. Using a triphasic 
model, Kandel et al also suggested that the CEP is a critical interface for bone-disc 
integration by providing an adhesive force that is resilient to shear loading [89]. In 
addition, they reported that the CEP may secret factors to stimulate proteoglycan and 
inhibit TNF-α production in NP cells, suggesting CEP has a role in regulating NP 
homeostasis [90]. The CEP is thought to be similar to articular cartilage, and can be 
artificially engineered by plating and incubating chondrocytes at a high density on the 
target interface where they secret matrices to model the interface into a cartilage layer 
[89,91]. 
 
Towards whole disc engineering 
By the time a degenerated disc becomes clinically symptomatic and requires 
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treatment, the AF and endplate, in addition to NP, are also structurally altered or 
functionally incompetent. In fact, at a severely degenerated stage, the motion segment 
is often largely compromised not only because of malfunction of the disc but also due 
to secondary arthritic changes such as facet joint degeneration and osteophyte 
formation. Transplantation of whole IVD appears to be a rational approach to replace 
severely degenerated spinal motion segments. This has been demonstrated recently in 
large animal models and in humans, where the transplantation of disc allografts was 
able to alleviate symptoms caused by the degenerated segment and thus a feasible 
option for treating disc degeneration [5,97]. However, it is still not clear if allografts 
may be routinely applied in practice due to the limited availability of non-degenerated 
disc tissue from healthy donors, and legislative regulations in utilizing human 
cadavers. Artificial disc installation may provide an alternative to overcome the issues. 
However, the application of artificial disc replacements may need to overcome 
additional hurdles such as recipient-graft integration and demand in surgical precision 
that could possibly be overcome using organic disc grafts due to their biological 
remodeling capacity [5]. 
 
While de novo bottom-up assembly of whole IVD is considered a challenging task, 
various attempts have been made to construct disc tissue prototypes with 
multi-compartmental features. Nesti et al [40] studied a biphasic model composing of 
an outer fibrous shell fabricated by electrospun nanofibers and an inner filling made 
of HA. Under stimulation with TGF, mesenchymal stem cells (MSCs) pre-implanted 
in the two compartments were able to differentiate, transforming the composite into 
AF- and NP-like structures. Mizuno et al [98] were able to produce an IVD-like tissue 
by generating a composite of AF cell-seeded synthetic polymer mesh wrapping 
around an NP cell-seeded alginate filling, which was subsequently implanted 
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subcutaneously for in vivo modeling and resulted in a collagen/proteoglycan-rich 
construct of enhanced mechanical properties. Another study by Wan et al [99] tested 
the fabrication of a dual-layer composite consisting of bone matrix gelatin in one 
phase and chondrocyte-seeded, concentrically oriented polymer in another to replicate 
the inner and outer AF. Hamilton et al [89] constructed a triphasic model to 
recapitulate the bone-CEP-NP organization. With the fabrication technique that 
replicates the angle-ply fiber organization of AF, Nerurkar et al engineered a 
biochemically and mechanically functional AF-NP composite with MSCs. 
Collectively, these studies reveal the possibility of artificially engineering discs which 
are similar anatomically and mechanically to the native disc, and thus have laid a 
valuable foundation for building a fully functional multi-scale disc composite for total 
disc replacement. Future efforts are anticipated to build a complete CEP-NP-AF 
architecture in order to simulate the higher-order complexity of native disc tissues. An 
osteochondral interface with proper zonal organization between vertebre and CEP 
may also need to be carefully engineered to obtain satisfactory structural and 
functional complexity, such as via a collagen microencapsulation-based multi-layer 
co-culture method [100]. 
 
Hurdles and perspectives 
The function of the IVD relies on an integrated dynamic interaction between the NP, 
AF and CEP. Therefore, de novo engineering of IVD would ultimately entail 
comprehensive knowledge in the biology and engineering techniques. At this stage, 
while the mechanical properties and functions of the individual compartments (i.e. NP, 
AF and CEP) have been fairly well studied, there is limited understanding in the 
interaction among the compartments. For instance, what components are present in 
the interface between NP and inner AF, and how AF/NP fibers are attached to the 
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CEP. This is analogous to the interface between tendon and bone, but with more 
complex mechanical moduli due to interplay among the disc compartments. 
 
Moreover, disc cell engineering appears to be one of the main hurdles in the progress 
of IVD bioengineering. This could be partly due to an incomplete understanding of 
their phenotypes and their modulation during disc development and homeostasis. 
Studies of animal and ex vivo culture models, such as transgenic mice and bioreactor 
systems, may provide clues, such as specific genes or signaling factors, necessary for 
the induction of progenitors or stem cells to become disc-related cell types, and to 
stably maintain the phenotype/characteristics of the derived cells in vitro. On the other 
hand, a better modeling of IVD microarchitecture may be achieved through molecular 
imaging and nanotechnology for better scaffold design and fabrication. 
 
The engineering of a complete IVD is the first step of many, but the true challenge 
lies in the production of a fully functional IVD. Within a decade, we will probably 
arrive at a stage that will enable complete bioengineering of all disc compartments. 
However, in the long-term there may be a limitation in the available fabrication 
technology that enables the assembly of the building blocks to establish overall disc 
biomechanics. Perhaps to overcome the issue, one might possibly fabricate a disc 
anlage, a primitive construct composing of distinctly engineered compartments, and 
subsequently allow the construct (the so-called precursor tissue analog [103]) to 
evolve to form a mature IVD through native morphogenetic activities of disc cells, 
mimicking tissue growth and remodeling during the post-natal maturation process of 
the IVD [7,9]. Such a strategy may be realized with future advances in disc cell 
engineering and bioreactor systems for whole IVD culturing with mechanical 
stimulation [63,95,104]. Perhaps with advancement in tissue engineering and total 
	   16	  
disc replacement devices, it may be possible to combine both disciplines to create 
hybrid constructs with strengths in bioactivity, mechanical function, and durability. 
 
Tissue engineering for IVD is at its infant stage when compared to articular cartilage 
engineering. However, in view of increasing the variety and sophistication of 
modalities available in cell biology, biomechanics, and tissue engineering, the 
bioengineering of whole functional IVD, and hence its clinical application, could 
eventuate in the not too distant future. 
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